Mandolin collects $ 40 million for AI automation for special medicines

Mandolin collects $ 40 million for AI automation for special medicines

1 minute, 30 seconds Read

Mandolin, a platform that uses AI automation to improve access to special medicines, has announced that it has obtained $ 40 million in financing.

Maverick, Signalfire, SV Angel, Greylock Partners, Jerry Yang (co -founder of Yahoo) and Guillermo Rauch (CEO of Vercel) participated in De Ronde.

What it does

Mandolin offers an AI-compatible workflow automation platform for use on the administrative side of special medicines. The AI ​​agents help with intake, earlier authorizations, benefits and income cycle management.

The San Francisco established Company says that its platform integrates into EPDs, manufacturer hubs and payer portals.

Mandolin His product launched in January and Touts that it is being used at more than 700 clinical locations.

“We will use this capital to grow the team, first and foremost aimed at World Class Engineering and customer implementation talent MobiHealthNews In an e -mail.

Market Snapshot

The total expenditure for special medicines increased from 21.7% in 2012 to 71.1% in 2021, according to a study published in the Journal of Managed Care and Specialty Pharmacy. Specialist medicines accounted for 6.2% of the recipes, but 71.1% of the total expenditure in 2021.

Other digital health companies that work in the specialist drug space include Serve RX, a pharmacy advantage manager, who announced a collaboration with Amazon Pharmacy in May to offer home delivery services for maintenance medication to its members.

You must use RX members access to common medicines, and specialist patients can use Waltz Health’s AI-driven platform to gain access to their special medicines.

In April, Mark Cuban Cost Plus Medicines announced a collaboration with specialty pharmaceutical distributor Morris & Dickson to offer access to injectable medicines via the costs plus marketplace.

Samacare, based in California, offers a workflow platform for providers that offer specialty medication. Last year the company assured $ 17 million in an overvalued series B investment round.

#Mandolin #collects #million #automation #special #medicines

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *